Clinical Study

A Phase Ib, Open-Label, Dose Escalation Trial Investigating Different Doses And Schedules Of Sym004 In Combination With Platinum-Doublets In Subjects

Posted Date: May 15, 2019

  • Investigator: John Morris
  • Type of Study: Drug

The purpose of a Phase I study is to find the best way to give an investigational drug (for example, by mouth, intravenous infusion, or injection) and/or the best dose. In Phase I studies, the dose is usually increased a little at a time until several participants have serious side effects.

Criteria:

To Qualify For This Study You Must Have Been Diagnosed With Stage Iv Nsclc.

Keywords:

Cancer, Lung, Emr200637-003, Nsclc, Stage Iv

For More Information:

Uc Cancer Center
513-584-7698
kastla@ucmail.uc.edu